|
|
|
| |
|
|
<![CDATA[<code id='A9A4AFF3E4'></code><style id='A9A4AFF3E4'></style>]]> | <![CDATA[<acronym id='A9A4AFF3E4'></acronym>]]><![CDATA[<center id='A9A4AFF3E4'><center id='A9A4AFF3E4'><tfoot id='A9A4AFF3E4'></tfoot></center><abbr id='A9A4AFF3E4'><dir id='A9A4AFF3E4'><tfoot id='A9A4AFF3E4'></tfoot><noframes id='A9A4AFF3E4'>]]>
| <![CDATA[<optgroup id='A9A4AFF3E4'><strike id='A9A4AFF3E4'><sup id='A9A4AFF3E4'></sup></strike><code id='A9A4AFF3E4'></code></optgroup>]]>
| |
|
|
| <![CDATA[<b id='A9A4AFF3E4'><label id='A9A4AFF3E4'><select id='A9A4AFF3E4'><dt id='A9A4AFF3E4'><span id='A9A4AFF3E4'></span></dt></select></label></b><u id='A9A4AFF3E4'></u>]]> | |
<![CDATA[<i id='A9A4AFF3E4'><strike id='A9A4AFF3E4'><tt id='A9A4AFF3E4'><pre id='A9A4AFF3E4'></pre></tt></strike></i>]]>|
人参与 | 时间：2025-07-06 19:54:45
- 医疗研发外包盈利能力PK：药康生物毛利率75%，医疗研发盈利药康医药药明博腾股份52%，外包凯莱英47%，生物泰格医药、毛利药明康德、率博莱英腾股泰格康龙化成超30% 2022年10月13日 15:10 市场资讯 顶: 7踩: 527
评论专区